2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$44.54+$0.63 (+1.43%)
Price as of Nov 11, 2026 5:23 PM EST- $826.8MMarket Cap
- 15.70%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$44.54+$0.63 (+1.43%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $43.91 | ||
Change | +$1.86 (+4.42%) | ||
Open | $42.15 | ||
High | $44.14 | ||
Low | $41.91 | ||
Previous Close | $42.05 | ||
Volume | 249,588 | ||
30-Day Average Volume | 245,138 | ||
1-Week Change | -10.13% | ||
1-Month Change | -10.53% | ||
1-Year Change | 15.70% | ||
3-Year Change | 436.86% | ||
5-Year Change | 36.79% | ||
Fundamentals | |||
Shares Outstanding | 18.8M | ||
Total Assets | $523.9M | ||
Market Cap | $826.8M | ||
Enterprise Value | $787.4M | ||
Period: QTR TTM FY | |||
Revenue | $72.3M | ||
Net Income | $13.2M | ||
Free Cash Flow | $34.6M | ||
EBIT | $17.7M | ||
EBITDA | $19.5M | ||
Net Working Capital | $109.8M | ||
EPS | $0.65 | ||
Enterprise Value/EBITDA | 40 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 2 | ||
P/E | 68 | ||
PEG | -3 | ||
Price/Free Cash Flow | 24 | ||
Price/Operating Cash Flow | 24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue